About Us
Aeon Respire's founders are bringing their extensive expertise in respiratory medicine to advance a better approach to achieve long-lasting and robust breathing health for millions. The company is advancing a novel inhaled drug that effectively blocks the source of pathologic calcium signaling in the lungs. This represents a new approach to treating severe asthma and other lung diseases and is differentiated by a unique mechanism of action. Aeon Respire's lead program AR-001 holds promise to address unmet need and disrupt existing treatments in large markets and to achieve blockbuster status.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Newbury Park, Ca 91320, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.aeonrespire.com
- Keywords
- asthma, inhaled therapy, respiratory disease, COPD, pulmonary fibrosis, pulmonary arterial hypertension.
- HQ
- Newbury Park, CA
Aeon Respire Questions
Aeon Respire's website is http://www.aeonrespire.com
Aeon Respire's LinkedIn profile is https://www.linkedin.com/company/aeon-respire
Aeon Respire has
3 employees.
View email and phone details for 3
employees at Aeon Respire.
Aeon Respire's industry is
Biotechnology Research
Aeon Respire's top competitors are
Eterna Biologics,
Neotes,
Glubio Therapeutics Inc,
Exosla Therapeutics,
Adrx, Inc.,
Three Sages,
Intima Bioscience,
Inhibox,
Neosphere Biotechnologies Gmbh,
Kyttaro Therapeutics.
Aeon Respire's categories are Biotechnology Research
Aeon Respire's founding year is 2019
